Cargando…

Calyxin Y sensitizes cisplatin-sensitive and resistant hepatocellular carcinoma cells to cisplatin through apoptotic and autophagic cell death via SCF βTrCP-mediated eEF2K degradation

The down-regulation of eukaryotic elongation factor-2 kinase (eEF2K) is associated with an enhancement in the sensitivity of malignant cells to chemotherapeutic agents. In this study, we found that the silencing of eEF2K enhanced cisplatin (CDDP)-induced cytotoxicity in CDDP-sensitive (HepG2) and re...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chao, Lei, Jian-Li, Zhang, Hao, Xia, Yuan-Zheng, Yu, Pei, Yang, Lei, Kong, Ling-Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642580/
https://www.ncbi.nlm.nih.gov/pubmed/29050305
http://dx.doi.org/10.18632/oncotarget.19883
_version_ 1783271395713613824
author Zhang, Chao
Lei, Jian-Li
Zhang, Hao
Xia, Yuan-Zheng
Yu, Pei
Yang, Lei
Kong, Ling-Yi
author_facet Zhang, Chao
Lei, Jian-Li
Zhang, Hao
Xia, Yuan-Zheng
Yu, Pei
Yang, Lei
Kong, Ling-Yi
author_sort Zhang, Chao
collection PubMed
description The down-regulation of eukaryotic elongation factor-2 kinase (eEF2K) is associated with an enhancement in the sensitivity of malignant cells to chemotherapeutic agents. In this study, we found that the silencing of eEF2K enhanced cisplatin (CDDP)-induced cytotoxicity in CDDP-sensitive (HepG2) and resistant (HepG2/CDDP) cells. Calyxin Y, a unique chalcone diarylheptanoid adduct, down-regulated eEF2K by promoting Skp1-Cul1-F-box protein (SCF) β-transducin repeat-containing protein (βTrCP)-mediated protein degradation and synergistically enhanced the cytotoxicity of CDDP. Subsequently, we identified a potential mechanism of this cooperative interaction by showing that the combination of calyxin Y and CDDP enhanced apoptotic cell death via mitochondrial dysfunction. In addition, the combination induced autophagy, which contributed to the synergistic cytotoxic effect. Further research revealed that calyxin Y synergistically sensitized HepG2 and HepG2/CDDP cells to CDDP through enhanced apoptotic and autophagic cell death via the SCF βTrCP-eEF2K pathway. Finally, in vivo studies demonstrated that calyxin Y could enhance the response of HepG2/CDDP cells to CDDP in xenograft models with low systemic toxicity. Thus, the combination of calyxin Y and CDDP might represent an attractive therapeutic strategy for the treatment of chemotherapy-sensitive and resistant hepatocellular carcinoma cells.
format Online
Article
Text
id pubmed-5642580
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-56425802017-10-18 Calyxin Y sensitizes cisplatin-sensitive and resistant hepatocellular carcinoma cells to cisplatin through apoptotic and autophagic cell death via SCF βTrCP-mediated eEF2K degradation Zhang, Chao Lei, Jian-Li Zhang, Hao Xia, Yuan-Zheng Yu, Pei Yang, Lei Kong, Ling-Yi Oncotarget Research Paper The down-regulation of eukaryotic elongation factor-2 kinase (eEF2K) is associated with an enhancement in the sensitivity of malignant cells to chemotherapeutic agents. In this study, we found that the silencing of eEF2K enhanced cisplatin (CDDP)-induced cytotoxicity in CDDP-sensitive (HepG2) and resistant (HepG2/CDDP) cells. Calyxin Y, a unique chalcone diarylheptanoid adduct, down-regulated eEF2K by promoting Skp1-Cul1-F-box protein (SCF) β-transducin repeat-containing protein (βTrCP)-mediated protein degradation and synergistically enhanced the cytotoxicity of CDDP. Subsequently, we identified a potential mechanism of this cooperative interaction by showing that the combination of calyxin Y and CDDP enhanced apoptotic cell death via mitochondrial dysfunction. In addition, the combination induced autophagy, which contributed to the synergistic cytotoxic effect. Further research revealed that calyxin Y synergistically sensitized HepG2 and HepG2/CDDP cells to CDDP through enhanced apoptotic and autophagic cell death via the SCF βTrCP-eEF2K pathway. Finally, in vivo studies demonstrated that calyxin Y could enhance the response of HepG2/CDDP cells to CDDP in xenograft models with low systemic toxicity. Thus, the combination of calyxin Y and CDDP might represent an attractive therapeutic strategy for the treatment of chemotherapy-sensitive and resistant hepatocellular carcinoma cells. Impact Journals LLC 2017-08-03 /pmc/articles/PMC5642580/ /pubmed/29050305 http://dx.doi.org/10.18632/oncotarget.19883 Text en Copyright: © 2017 Zhang et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Zhang, Chao
Lei, Jian-Li
Zhang, Hao
Xia, Yuan-Zheng
Yu, Pei
Yang, Lei
Kong, Ling-Yi
Calyxin Y sensitizes cisplatin-sensitive and resistant hepatocellular carcinoma cells to cisplatin through apoptotic and autophagic cell death via SCF βTrCP-mediated eEF2K degradation
title Calyxin Y sensitizes cisplatin-sensitive and resistant hepatocellular carcinoma cells to cisplatin through apoptotic and autophagic cell death via SCF βTrCP-mediated eEF2K degradation
title_full Calyxin Y sensitizes cisplatin-sensitive and resistant hepatocellular carcinoma cells to cisplatin through apoptotic and autophagic cell death via SCF βTrCP-mediated eEF2K degradation
title_fullStr Calyxin Y sensitizes cisplatin-sensitive and resistant hepatocellular carcinoma cells to cisplatin through apoptotic and autophagic cell death via SCF βTrCP-mediated eEF2K degradation
title_full_unstemmed Calyxin Y sensitizes cisplatin-sensitive and resistant hepatocellular carcinoma cells to cisplatin through apoptotic and autophagic cell death via SCF βTrCP-mediated eEF2K degradation
title_short Calyxin Y sensitizes cisplatin-sensitive and resistant hepatocellular carcinoma cells to cisplatin through apoptotic and autophagic cell death via SCF βTrCP-mediated eEF2K degradation
title_sort calyxin y sensitizes cisplatin-sensitive and resistant hepatocellular carcinoma cells to cisplatin through apoptotic and autophagic cell death via scf βtrcp-mediated eef2k degradation
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642580/
https://www.ncbi.nlm.nih.gov/pubmed/29050305
http://dx.doi.org/10.18632/oncotarget.19883
work_keys_str_mv AT zhangchao calyxinysensitizescisplatinsensitiveandresistanthepatocellularcarcinomacellstocisplatinthroughapoptoticandautophagiccelldeathviascfbtrcpmediatedeef2kdegradation
AT leijianli calyxinysensitizescisplatinsensitiveandresistanthepatocellularcarcinomacellstocisplatinthroughapoptoticandautophagiccelldeathviascfbtrcpmediatedeef2kdegradation
AT zhanghao calyxinysensitizescisplatinsensitiveandresistanthepatocellularcarcinomacellstocisplatinthroughapoptoticandautophagiccelldeathviascfbtrcpmediatedeef2kdegradation
AT xiayuanzheng calyxinysensitizescisplatinsensitiveandresistanthepatocellularcarcinomacellstocisplatinthroughapoptoticandautophagiccelldeathviascfbtrcpmediatedeef2kdegradation
AT yupei calyxinysensitizescisplatinsensitiveandresistanthepatocellularcarcinomacellstocisplatinthroughapoptoticandautophagiccelldeathviascfbtrcpmediatedeef2kdegradation
AT yanglei calyxinysensitizescisplatinsensitiveandresistanthepatocellularcarcinomacellstocisplatinthroughapoptoticandautophagiccelldeathviascfbtrcpmediatedeef2kdegradation
AT konglingyi calyxinysensitizescisplatinsensitiveandresistanthepatocellularcarcinomacellstocisplatinthroughapoptoticandautophagiccelldeathviascfbtrcpmediatedeef2kdegradation